TITLE

Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice

AUTHOR(S)
Lim, Young-Cheol; Bhatt, Mahendra Prasad; Kwon, Mi-Hye; Park, Donghyun; Lee, Seungkoo; Choe, Jongseon; Hwang, JongYun; Kim, Young-Myeong; Ha, Kwon-Soo
PUB. DATE
January 2014
SOURCE
Cardiovascular Research;Jan2014, Vol. 101 Issue 1, p155
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aims Human C-peptide has a beneficial effect on the prevention of diabetic neuropathy, nephropathy, and vascular complications; however, its role in protection against increased vascular permeability in diabetes remains unclear. Our purpose was to explore the potential protective role of C-peptide against microvascular permeability mediated by vascular endothelial growth factor (VEGF)-induced reactive oxygen species (ROS) generation in diabetes. Methods and results Generation of intracellular ROS, real-time changes in intracellular Ca2+, ROS-dependent stress fibre formation, and the disassembly of the adherens junctions were studied by a confocal microscopy in human umbilical vein endothelial cells (HUVECs). VEGF-induced vascular leakage was investigated in the skin of diabetic mice using a Miles vascular permeability assay. Microvascular leakage in the retina of streptozotocin diabetic mice was investigated using a confocal microscopy after left ventricle injection of fluorescein isothiocyanate (FITC)-dextran. C-peptide inhibited the VEGF-induced ROS generation, stress fibre formation, disassembly of vascular endothelial cadherin, and endothelial permeability in HUVECs. Intradermal injection of C-peptide prevented VEGF-induced vascular leakage. Consistent with this, intravitreal injection of C-peptide prevented the extravasation of FITC-dextran in the retinas of diabetic mice, which was also prevented by anti-VEGF antibody and ROS scavengers in diabetic mice. Conclusions/interpretation C-peptide prevents VEGF-induced microvascular permeability by inhibiting ROS-mediated intracellular events in diabetic mice, suggesting that C-peptide replacement is a promising therapeutic strategy to prevent diabetic retinopathy.
ACCESSION #
93398933

 

Related Articles

  • Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy. Ziyadeh, Fuad N.; Wolf, Gunter // Current Diabetes Reviews;2008, Vol. 4 Issue 1, p39 

    Microalbuminuria is the earliest detectable clinical abnormality in diabetic glomerulopathy. On a molecular level, metabolic pathways activated by hyperglycemia, glycated proteins, hemodynamic factors, and oxidative stress are key players in the genesis of diabetic kidney disease. A variety of...

  • Salutary Effect of Pigment Epithelium-Derived Factor in Diabetic Nephropathy. Wang, Joshua J.; Zhang, Sarah X.; Mott, Robert; Knapp, Ryan R.; Cao, Wei; Lau, Kai; Ma, Jian-xing // Diabetes;Jun2006, Vol. 55 Issue 6, p1678 

    Diabetic nephropathy is a major complication of diabetes and a leading cause of end-stage renal diseases in the U.S. Pigment epithelium-derived factor (PEDF) is a potent angiogenic inhibitor that has been extensively studied in diabetic retinopathy. Recently, we reported that PEDF is expressed...

  • The Therapeutic Potential of VEGF Inhibition in Diabetic Microvascular Complications. Tremolada, Gemma; Lattanzio, Rosangela; Mazzolari, Gabriella; Zerbini, Gianpaolo // American Journal of Cardiovascular Drugs;2007, Vol. 7 Issue 6, p393 

    During the last few years, the incidence of microvascular complications in diabetes mellitus has rapidly increased as a consequence of both an increase in incidence of type 2 and type 1 diabetes mellitus. The pathogenesis of diabetic microvascular complications is still largely unknown. Among...

  • Does suppression of VEGF alone lead to clinical recovery in POEMS syndrome? Kimiyoshi Arimura // Journal of Neurology, Neurosurgery & Psychiatry;Dec2013, Vol. 84 Issue 12, p1301 

    The author reports that suppression of vascular endothelial growth factor (VEGF) is not sufficient for the treatment of POEMS syndrome. An overview of pathology of the disease and the efficiency of treatments including stem cell transplantation thalidomide to target plasma cells, which are main...

  • The eye and the kidney: twin targets in diabetes. Raju, T.; Madhavi, N.; Sridhar, G. // International Journal of Diabetes in Developing Countries;Nov2015 Supplement, Vol. 35, p299 

    An introduction is presented in which the editor discusses various reports within the issue on topics including prevalence of retinopathy in India which affect the eye and the kidney; vascular endothelial growth factor (VEGF); and relation between diabetic nephropathy (DN) and retinopathy (DR).

  • Role of the Retinal Müller Cells in Retinal Neovascularization. Le, Yun Z.; Ma, Jian-Xing; Zheng, Wei; Chen, Ying; Gerber, Hans Peter; Ferrara, Napoleone; Zhu, Meili // Diabetes;Jun2007 Supplement 1, Vol. 56, pA215 

    Retinal neovascularization and retinal vascular leakage are the common pathogenic changes and major causes of vision loss in diabetic patients. Over-expression of vascular endothelial growth factor (VEGF or VEGF-A) in diabetic retina plays a pivotal role in these pathogenic changes. It has been...

  • Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice. Ku, Ching-Hsin; White, Kathryn E.; Cas, Alessandra Dei; Hayward, Anthea; Webster, Zoe; Bilous, Rudy; Marshall, Sally; Viberti, Giancarlo; Gnudi, Luigi // Diabetes;Oct2008, Vol. 57 Issue 10, p2824 

    OBJECTIVE--Podocyte-specific, doxycycline (DOX)-inducible overexpression of soluble vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1) in adult mice was used to investigate the role of the VEGF-A/VEGF receptor (VEGFR) system in diabetic glomerulopathy. RESEARCH DESIGN AND METHODS--We...

  • Adiponectin Fails in Improving Angiogenic Repair in Streptozocin-Treated or Leprdb/db Mice after Hind Limb Ischemia. Belisle, Kurt; Andrassy, Martin; Schneider, Jochen; Schiekofer, Stephan // ISRN Vascular Medicine;2012, p1 

    Objectives. Type 1 and 2 diabetes carry risk factors for the development of microvascular diseases with associated impairment of angiogenic repair. Here, we investigated whether adiponectin, an adipocyte-specific adipocytokine with antiatherosclerotic and antidiabetic properties, regulates...

  • AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. Zhang, Haifeng; He, Yun; Dai, Shengchuan; Xu, Zhe; Luo, Yan; Wan, Ting; Luo, Dianhong; Jones, Dennis; Tang, Shibo; Chen, Hong; Sessa, William C.; Min, Wang // Journal of Clinical Investigation;Dec2008, Vol. 118 Issue 12, p1 

    ASK1-interacting protein-1 (AIP1), a recently identified member of the Ras GTPase-activating protein family, is highly expressed in vascular ECs and regulates EC apoptosis in vitro. However, its function in vivo has not been established. To study this, we generated AIP1-deficient mice (KO mice)....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics